Safety and efficacy of vinorelbine in combination with pertuzumab and trastuzumab for first-line treatment of patients with HER2-positive locally advanced or metastatic breast cancer: VELVET Cohort 1 final results

BACKGROUND: Pertuzumab, trastuzumab, and docetaxel is standard of care for first-line treatment of HER2-positive metastatic breast cancer (MBC). However, alternative chemotherapy partners are required to align with patient/physician preferences and to increase treatment flexibility. We report VELVET...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Breast Cancer Res
Main Authors: Perez, Edith A., López-Vega, José Manuel, Petit, Thierry, Zamagni, Claudio, Easton, Valerie, Kamber, Julia, Restuccia, Eleonora, Andersson, Michael
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5154110/
https://ncbi.nlm.nih.gov/pubmed/27955684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-016-0773-6
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki